Please login to the form below

Not currently logged in
Email:
Password:

pregabalin

This page shows the latest pregabalin news and features for those working in and with pharma, biotech and healthcare.

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

rival to Pfizer’s big-selling Lyrica (pregabalin) brand which brought in $4.7bn last year despite generic competition in some markets. ... The challenge for Daiichi Sankyo with mirogabalin will be positioning it as a realistic alternative to pregabalin

Latest news

More from news
Approximately 0 fully matching, plus 25 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics